Xenetic Biosciences Inc – Quartals-Cashflow (NASDAQ:XBIO) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 6.9 M5.79 M5.35 M5.07 M8.36 M Gesamtverbindlichkeiten 894.26 K667.93 K903.43 K1.11 M968.02 K Gesamtkapital 6.01 M5.12 M4.45 M3.96 M7.4 M Gesamtverbindlichkeiten und Eigenkapital 6.9 M5.79 M5.35 M5.07 M8.36 M Gesamtverschuldung ————— Nettoverschuldung —————

Nachrichten

Xenetic Biosciences verlängert Forschungskooperation mit Scripps Research

Xenetic Biosciences extends collaboration with Scripps Research

Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges - Galecto (NASDAQ:GLTO), Micron Technology (NASDAQ:MU), Xenetic Biosciences (NASDAQ:XBIO)

Xenetic Biosciences platziert Aktienemission im Wert von 4,5 Millionen US-Dollar

Xenetic Biosciences prices $4.5 million common stock offering

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings - Galecto (NASDAQ:GLTO)

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Ambow Education Holding (AMEX:AMBO)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.00%

Nasdaq Gains 150 Points; US Mortgage Applications Decline - AlphaTON Capital (NASDAQ:ATON), Envoy Medical (NASDAQ:COCH)

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), AlphaTON Capital (NASDAQ:ATON)

Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates